Preferential location of circulating activated cyclophosphamide within the erythrocyte [1]

International Journal of Cancer

Volumn 65, Issue 5, 1996, Pages 711-

  Highley, M S ^a   Harper, P G ^a   Slee Th , P H J ^a   De Bruijn, E A ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LETTER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; ERYTHROCYTES; FEMALE; HUMANS; HYDROXYLATION;

EID: 0030002017     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(19960301)65:5<711::AID-IJC2910650503>3.0.CO;2-H     Document Type: Letter

References (0)